Novavax to Host Conference Call and Webcast to Provide Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
Get Alerts NVAX Hot Sheet
Join SI Premium – FREE
GAITHERSBURG, Md., March 07, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will provide a corporate update and report its fourth quarter and full year 2017 financial and operating results following the close of U.S. financial markets on Wednesday, March 14, 2018.
Conference call and webcast details are as follows: | |
Date: | March 14, 2018 |
Time: | 5:00 p.m. U.S. Eastern Time (ET) |
Dial-in number: | (877) 212-6076 (Domestic) or (707) 287-9331 (International) |
Passcode: | 6472939 |
Webcast: | www.novavax.com, “Investors”/ “Events” |
Conference call and webcast replay: | |
Dates: | Starting at 8:00 p.m. ET, March 14, 2018 until |
9:00 p.m. ET March 21, 2018 | |
Dial-in number: | (855) 859-2056 (Domestic) or (404) 537-3406 (International) |
Passcode: | 6472939 |
Webcast: | www.novavax.com, “Investors”/ “Events”, until June 14, 2018 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases. Our RSV and influenza nanoparticle vaccine candidates are Novavax’ most advanced clinical programs and are at the forefront of the Company’s efforts to improve global health. Additional information about Novavax is available on the Company's website, novavax.com.
Contact:
InvestorsWestwicke PartnersJohn Woolford[email protected]443-213-0506
MediaSam BrownMike Beyer[email protected]312-961-2502
Source: Novavax, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chevron (CVX) earnings fall short while revenue tops estimates in Q1
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- U.S. Silica (SLCA) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!